Board Meetings for SUNPHARMA
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | 29 May 2015 | Results/Others | Interalia to consider and approve the audited financial results of the Company stand alone and consolidated for the year ended March 31, 2015. The said audited results are subject to revision so as to give effect of amalgamation of Sun Pharma Global Inc, our wholly owned subsidiary company, with the Company with effect from January 1, 2015, after receipt of all required approvals from the statutory authorities in respect of the amalgamation. | |
| SUNPHARMA | Sun Pharmaceutical Industries Limited | 14 Feb 2015 | Results | Inter alia, to consider and take on record the Unaudited Financial Results of the Company for the third quarter and nine months ended December 31, 2014. | - |
| SUNPHARMA | Sun Pharmaceutical Industries Limited | 13 Nov 2014 | Results | inter alia, to consider and take on record the un-audited financial results of the Company for the second quarter ended September 30, 2014. | - |
| SUNPHARMA | Sun Pharmaceutical Industries Limited | 12 Aug 2014 | Results/Dividend | The Board of Directors of the Company would meet on August 12, 2014 to transact, inter alia, the following business. (i) Consider the revised audited annual accounts of the Company for the year ended March 31, 2014 after giving the effect to the above mentioned Scheme of Arrangement and Reconstruction between SPIL and SPGFZE. (ii) To consider the recommendation of payment of dividend on equity shares for the year ended March 31, 2014 subject to the approval of the shareholders at the ensuing Annual General Meeting. (iii) To consider and take on record the un-audited financial results of the Company for the first quarter ended June 30, 2014 (Q1). The window closure for Trading by Designated persons as per Insider Trading Rules of the Company will be from August 01, 2014 to August 14, 2014 (both days inclusive). | - |
| SUNPHARMA | Sun Pharmaceutical Industries Limited | 29 May 2014 | Results/Others | Inter alia, to consider and approve the audited financial results of the Company stand alone and consolidated for the year ended March 31, 2014. The said audited results are subject to revision so as to give effect of demerger with effect from May 01, 2013 of the Specified Undertaking of Sun Pharma Global FZE, the Company's wholly owned subsidiary company with the Company, after receipt of all required approvals from the statutory authorities in respect of the demerger. Further, note that window closure for Trading by Designated persons as per Insider Trading Rules of the Company will be from May 20, 2014 to June 02, 2014 (both days inclusive). | |
| SUNPHARMA | Sun Pharmaceutical Industries Limited | 13 Feb 2014 | Results | Interalia, to consider and take on record the un-audited financial results of the Company for the third quarter ended December 31, 2013. | - |
| SUNPHARMA | Sun Pharmaceutical Industries Limited | 13 Nov 2013 | Results | Interalia, to consider and take on record the un-audited financial results of the Company for the second quarter / half year ended September 30, 2013. | - |
| SUNPHARMA | Sun Pharmaceutical Industries Limited | 09 Aug 2013 | Results | Interalia, to consider and take on record the un-audited financial results of the Company for the first quarter ended June 30, 2013 | - |
| SUNPHARMA | Sun Pharmaceutical Industries Limited | 28 May 2013 | Scheme of Arrangement | The Company has informed that the Hon'ble High Court of Gujarat, at Ahmedabad and Hon'ble High Court of Mumbai, at their respective hearing held both on May 03, 2013 approved the Scheme of Arrangement between Sun Pharmaceutical Industries Limited (SPIL) and Sun Pharma Laboratories Limited (SPLL) in the nature of Spin-Off and transfer of Domestic Formulation Business/Undertaking of SPIL to SPLL with effect from the appointed date of March 31, 2012. Further, the Company has informed that the certified copies of the High Court orders will be filed with the Registrar of Companies shortly as required and the spin off process would get completed. Further, in view thereof, the Board of Directors of the Company would also consider the revised audited annual accounts of the Company for the year ended March 31, 2012 after giving the effect to the above mentioned Scheme of Arrangement between SPIL and SPLL (along with the consideration of audited annual accounts of the Company for the year ended March 31, 2013) at their meeting to be held on May 28, 2013. | - |
| SUNPHARMA | Sun Pharmaceutical Industries Limited | 28 May 2013 | Results/Dividend | Interalia, (1) To consider and approve the audited financial results of the Company for the year ended March 31, 2013; (2) To consider the recommendation of payment of dividend for the year ended March 31, 2013, subject to the approval of the shareholders at the ensuing Annual General Meeting. | - |
| SUNPHARMA | Sun Pharmaceutical Industries Limited | 08 Feb 2013 | Results | Inter-alia, to consider and take on record the un-audited financial results of the Company for the third quarter ended December 31, 2012. | - |
| SUNPHARMA | Sun Pharmaceutical Industries Limited | 08 Nov 2012 | Un-audited Financial Results | Interalia, to consider and take on record the un-audited financial results of the Company for the second quarter / half year ended September 30, 2012. | - |
| SUNPHARMA | Sun Pharmaceutical Industries Limited | 10 Aug 2012 | Results/Dividend | The Company had informed the Exchange regarding a Board meeting to be held on August 10, 2012 interalia, to consider and take on record the un-audited financial results of the Company for the first quarter ended June 30, 2012. The Company has now informed the Exchange that Board meeting to be held on August 10, 2012 to consider the quarterly unaudited results of the Company interalia, the following additional agenda items also would be considered : (i) To consider the internal restructuring of the business of the Company with effect from March 31,2012. (ii) To consider declaration of the interim dividend of Rs.4.25 per Share of Re.1 each on Equity Shares of the Company for the year ended March 31, 2012 in lieu of the earlier recommended proposed dividend of Rs.4.25 per Share of Re.1 each on Equity Shares of the Company for the year ended March 31, 2012 in view of the likely delay for the redrawing and audit of the revised accounts for the year ended March 31, 2012 and adoption of accounts by the members due to the proposed restructuring of the business of the Company with effect from March 31,2012, if the Board approves the proposed restructuring. (Purpose Revised) | - |
| SUNPHARMA | Sun Pharmaceutical Industries Limited | 10 Aug 2012 | Un-audited Financial Results | Interalia, to consider and take on record the un-audited financial results of the Company for the first quarter ended June 30, 2012. | - |
| SUNPHARMA | Sun Pharmaceutical Industries Limited | 29 May 2012 | Results/Dividend | Interalia, (1) To consider and approve the audited financial results of the Company for the year ended March 31, 2012; (2) To consider the recommendation of payment of dividend on equity shares for the year ended March 31, 2012, subject to the approval of the shareholders at the ensuing Annual General Meeting. | - |